Protective effect of saxagliptin against renal ischaemia reperfusion injury in rats

dc.contributor.authorTekin, Suat
dc.contributor.authorBeytur, Asiye
dc.contributor.authorCakir, Murat
dc.contributor.authorTaslidere, Ash
dc.contributor.authorErden, Yavuz
dc.contributor.authorTekin, Cigdem
dc.contributor.authorSandal, Suleyman
dc.contributor.authorErden, Yavuz
dc.date.accessioned2025-10-18T10:05:00Z
dc.date.created2020
dc.date.issued2020
dc.departmentFakülteler, Fen Fakültesi, Moleküler Biyoloji ve Genetik Bölümü
dc.description.abstractSaxagliptin is an effective and selective dipeptidyl peptidase-4 (DPP-4) inhibitor. This study was designed to determine possible protective effects of saxagliptin against damage caused by renal ischaemia/reperfusion (I/R) in rats. In this study, 40 rats were divided into 4 groups (n = 10 for each). Group 1 (Control), Group 2 (I/R) in both kidneys ischaemia of 45 min was performed, and then reperfusion was applied for 24 h. Saxagliptin (Group 3: 2 mg/kg and Group 4: 10 mg/kg) was administered by oral gavage to the animals in treatment groups, before the I/R. Saxagliptin decreased the markers (BUN, Cre, NGAL, KIM-1 and IL-18) of acute renal damage in blood and kidney tissue. Saxagliptin provided increase in antioxidant enzyme levels and decrease in MDA and apoptosis. Histological results showed that the administration of saxagliptin exhibited a protective effect against renal damage caused by I/R. These results indicates that saxagliptin provide protection against kidney injury caused by I/R.
dc.description.sponsorshipInonu University Scientific Research Projects Fund [TCD-2017-647]
dc.description.sponsorshipThis study was supported by Inonu University Scientific Research Projects Fund [Project #TCD-2017-647].
dc.identifier.doi10.1080/13813455.2020.1715442
dc.identifier.endpage618
dc.identifier.issn1381-3455
dc.identifier.issn1744-4160
dc.identifier.issue3
dc.identifier.orcidTekin, Suat/0000-0002-2757-1802
dc.identifier.orcidErden, Yavuz/0000-0002-2807-6096
dc.identifier.orcidCAKIR, MURAT/0000-0002-2066-829X
dc.identifier.orcidCETIN, Asli/0000-0003-3902-3210
dc.identifier.orcidTEKIN, CIGDEM/0000-0001-9038-1924;
dc.identifier.pmid31979992
dc.identifier.scopus2-s2.0-85078474005
dc.identifier.scopusqualityQ2
dc.identifier.startpage608
dc.identifier.urihttps://doi.org/10.1080/13813455.2020.1715442
dc.identifier.urihttps://hdl.handle.net/11772/20998
dc.identifier.volume128
dc.identifier.wosWOS:000509173800001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofArchives of Physiology and Biochemistry
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzWoS_20251016
dc.subjectDipeptidyl Peptidase-4 Inhibitor
dc.subjectOxidative Stress
dc.subjectSaxagliptin
dc.subjectRenal Ischaemia Reperfusion
dc.subjectLipid Peroxidation
dc.titleProtective effect of saxagliptin against renal ischaemia reperfusion injury in rats
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublication03e83980-c1b3-4acd-94a9-b6bc0b0a5695
relation.isAuthorOfPublication.latestForDiscovery03e83980-c1b3-4acd-94a9-b6bc0b0a5695

Dosyalar